These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1842117)

  • 1. [Ceruloplasmin in patients with Duchenne muscular dystrophy].
    Reyes J; Holmgren J; Colombo M
    Rev Med Chil; 1991 Mar; 119(3):258-61. PubMed ID: 1842117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
    Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
    Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection.
    Passos MR; Gonzalez CH; Zatz M
    Am J Med Genet; 1985 Oct; 22(2):255-62. PubMed ID: 4050856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification of the carrier state in the severe recessive X-linked muscular dystrophy (Duchenne type). I. Assay of activated serum creatine kinase activity in serum (author's transl)].
    Rotthauwe HW; Kowalewski S
    Z Kinderheilkd; 1973 Nov; 115(4):333-42. PubMed ID: 4591596
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood myoglobin in children with progressive muscular dystrophy and in carriers].
    Calandi C; Baretti S; Pacciani G; Bagni P; Borsotti M; Tozzi P; Adami Lami C
    Quad Sclavo Diagn; 1984 Dec; 20(4):391-8. PubMed ID: 6537549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pedigree testing in Duchenne muscular dystrophy.
    Roses AD; Roses MJ; Metcalf BS; Hull KL; Nicholson GA; Hartwig GB; Roe CR
    Ann Neurol; 1977 Oct; 2(4):271-8. PubMed ID: 617266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter: Follow-up study of serum-creatine-kinase in carriers of Duchenne muscular dystrophy.
    Moser H; Vogt J
    Lancet; 1974 Sep; 2(7881):661-2. PubMed ID: 4137773
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of carrier detection of Duchenne muscular dystrophy using carbonic anhydrase III and creatine kinase.
    Heath R; Carter ND; Jeffery S; Edwards RJ; Watts DC; Watts RL
    Am J Med Genet; 1985 Jun; 21(2):291-6. PubMed ID: 3925781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An examination of some factors influencing creatine kinase in the blood of patients with muscular dystrophy.
    Jackson MJ; Round JM; Newham DJ; Edwards RH
    Muscle Nerve; 1987 Jan; 10(1):15-21. PubMed ID: 3561434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum creatine kinase isoenzymes in Duchenne muscular dystrophy determined by sensitive enzyme immunoassay methods.
    Mokuno K; Riku S; Sugimura K; Takahashi A; Kato K; Osugi S
    Muscle Nerve; 1987 Jun; 10(5):459-63. PubMed ID: 3302699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection.
    Griggs RC; Mendell JR; Brooke MH; Fenichel GM; Miller JP; Province M; Moxley RT; Huntzinger D; Vaughn A; Cohen M
    Muscle Nerve; 1985 Jan; 8(1):60-7. PubMed ID: 4058458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duchenne muscular dystrophy and idiopathic hyperCKemia in a family causing confusion in genetic counselling.
    Bushby K; Goodship J; Haggerty D; Heald A; Walls T
    Am J Med Genet; 1996 Dec; 66(2):237-8. PubMed ID: 8958338
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum alpha-galactosidase activity in children with Duchenne-type muscular dystrophy and in gene carriers.
    László A; Havass Z
    Acta Paediatr Hung; 1983; 24(4):327-9. PubMed ID: 6324830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier detection in Duchenne muscular dystrophy.
    Roses AD; Roses MJ; Miller SE; Hull KL; Appel SH
    N Engl J Med; 1976 Jan; 294(4):193-8. PubMed ID: 1244534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biochemical, histological and clinical findings in carriers of Duchenne-type progressive muscular dystrophy].
    Moser H; Mumenthaler M; Wiesmann U
    Schweiz Med Wochenschr; 1971 Apr; 101(15):537-42. PubMed ID: 5576948
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic membrane defect in the proximal muscular dystrophies.
    Pickard NA; Gruemer HD; Verrill HL; Isaacs ER; Robinow M; Nance WE; Myers EC; Goldsmith B
    N Engl J Med; 1978 Oct; 299(16):841-6. PubMed ID: 308614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier detection in X-linked muscular dystrophy.
    Walton JN
    J Genet Hum; 1969 Oct; 17(3):497-510. PubMed ID: 5387424
    [No Abstract]   [Full Text] [Related]  

  • 18. The significance of changes in the blood serum electrolytes in the detection of heterozygous carriers of Duchenne myopathy.
    Grinio LP
    Sov Genet; 1974 Mar; 7(12):1596-9. PubMed ID: 4827770
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum pyruvate-kinase (PK) activity during pregnancy in potential carriers for Duchenne muscular dystrophy.
    Zatz M; Passos MR; Bortolini ER
    Am J Med Genet; 1983 May; 15(1):149-51. PubMed ID: 6859115
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of discriminant analysis of serum creatine kinase levels for detection of heterozygote carriers of Duchenne muscular dystrophy].
    Krasil'nikov VV; Labeznik TA; Shilov LA
    Genetika; 1987 Jan; 23(1):176-9. PubMed ID: 3817468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.